|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 47/48 | |
| A61P 7/04 |
| (11) | Patento numeris | 1677829 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04768770.2 |
| Europos patento paraiškos padavimo data | 2004-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-07-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2004/004235 |
| Data | 2004-10-07 |
| (87) | Numeris | WO 2005/035002 |
| Data | 2005-04-21 |
| (30) | Numeris | Data | Šalis |
| 0323378 | 2003-10-07 | GB |
| (72) |
GOODALL, Alison Helena, GB
MIDDLETON, Sarah Margaret, GB
|
| (73) |
Haemostatix Limited,
Bio City Nottingham Pennyfoot Street, Nottingham NG1 1GF,
GB
|
| (54) | FIBRINOGEN TARGETTING MICROPARTICLES FOR PROMOTING HAEMOSTASIS |
| FIBRINOGEN TARGETTING MICROPARTICLES FOR PROMOTING HAEMOSTASIS |